X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES SANOFI INDIA ALKEM LABORATORIES/
SANOFI INDIA
 
P/E (TTM) x - 34.3 - View Chart
P/BV x 6.7 6.9 97.2% View Chart
Dividend Yield % 0.6 1.3 49.4%  

Financials

 ALKEM LABORATORIES   SANOFI INDIA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
SANOFI INDIA
Dec-16
ALKEM LABORATORIES/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,5894,560 34.8%   
Low Rs1,2324,400 28.0%   
Sales per share (Unadj.) Rs417.51,028.5 40.6%  
Earnings per share (Unadj.) Rs56.3129.0 43.7%  
Cash flow per share (Unadj.) Rs64.7186.0 34.8%  
Dividends per share (Unadj.) Rs12.7068.00 18.7%  
Dividend yield (eoy) %0.91.5 59.3%  
Book value per share (Unadj.) Rs292.9753.6 38.9%  
Shares outstanding (eoy) m119.5723.03 519.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.44.4 77.6%   
Avg P/E ratio x25.134.7 72.1%  
P/CF ratio (eoy) x21.824.1 90.5%  
Price / Book Value ratio x4.85.9 81.0%  
Dividend payout %22.652.7 42.8%   
Avg Mkt Cap Rs m168,653103,174 163.5%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m9,1713,592 255.3%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m49,91523,686 210.7%  
Other income Rs m1,645708 232.4%   
Total revenues Rs m51,56124,394 211.4%   
Gross profit Rs m8,4825,281 160.6%  
Depreciation Rs m1,0061,313 76.6%   
Interest Rs m67115 4,470.7%   
Profit before tax Rs m8,4514,661 181.3%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6061,691 95.0%   
Profit after tax Rs m6,7312,970 226.6%  
Gross profit margin %17.022.3 76.2%  
Effective tax rate %19.036.3 52.4%   
Net profit margin %13.512.5 107.5%  
BALANCE SHEET DATA
Current assets Rs m27,06215,673 172.7%   
Current liabilities Rs m15,3246,678 229.5%   
Net working cap to sales %23.538.0 61.9%  
Current ratio x1.82.3 75.2%  
Inventory Days Days6776 87.5%  
Debtors Days Days4122 185.0%  
Net fixed assets Rs m12,6108,098 155.7%   
Share capital Rs m239230 103.8%   
"Free" reserves Rs m34,49017,088 201.8%   
Net worth Rs m35,02717,356 201.8%   
Long term debt Rs m1,2120-   
Total assets Rs m54,38725,400 214.1%  
Interest coverage x13.6311.7 4.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.9 98.4%   
Return on assets %13.611.8 115.8%  
Return on equity %19.217.1 112.3%  
Return on capital %24.926.9 92.3%  
Exports to sales %12.924.5 52.9%   
Imports to sales %3.128.0 11.0%   
Exports (fob) Rs m6,4615,801 111.4%   
Imports (cif) Rs m1,5406,627 23.2%   
Fx inflow Rs m6,5637,145 91.9%   
Fx outflow Rs m3,0126,846 44.0%   
Net fx Rs m3,552299 1,187.8%   
CASH FLOW
From Operations Rs m7,2593,226 225.0%  
From Investments Rs m1,864-1,555 -119.9%  
From Financial Activity Rs m-9,273-1,818 510.0%  
Net Cashflow Rs m-150-147 102.0%  

Share Holding

Indian Promoters % 66.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 33.1 14.4 229.9%  
FIIs % 0.0 14.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 10.5 -  
Shareholders   68,381 15,184 450.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  TTK HEALTHCARE  SUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jun 19, 2018 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - NOVARTIS COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS